The public offering involved 16 million units, with each unit consisting of one share of common stock, according to a Feb. 15 news release.
Biolase has 241 patented and 21 patent-pending laser technologies aimed at helping dental professionals perform procedures with less pain for patients and faster recovery times.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place November 12–14 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
